Floatz logo

Teonanacatl

Hematopoietic And Lymphoid System Neoplasm

Roswell Park Cancer InstituteSmall moleculePhase 2Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
81/ 100

Competitive context

133 Active assets in the Hematopoietic And Lymphoid System Neoplasm cohort.

Asset / SponsorPhaseRating
Adriamycin
OHSU Knight Cancer Institute
Phase 4BBB
Teclistamab
Janssen Pharmaceutical K.K.
Phase 2BB
Dexasone
City of Hope Medical Center
Phase 3BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 3BB
Allogeneic, Ex Vivo Expanded, Umbilical Cord Blood-Derived Hematopoietic Cd133+ Progenitor Cells- Cultured Fraction (Cf)
Gamida Cell ltd
Phase 3BB

View all 50 →

Same molecule, other indications

Teonanacatl is also rated in:

depressive disorderActive
BB
Indicative · Phase 2
68 / 100
View asset →
major depressive disorderActive
BB
Indicative · Phase 3
65 / 100
View asset →
bipolar II disorderActive
B
Indicative · Phase 3
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →